Cargando…

Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer

Purpose: This study analyzed the association between sex hormone concentrations and stage/condition in patients with prostate cancer. Materials and methods: The concentrations of sex hormones, including testosterone (total, free, and bioavailable), sex hormone-binding globulin (SHBG), luteinizing ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Se Young, Chi, Byung Hoon, Lee, Wonchul, Lim, Bumjin, You, Dalsan, Kim, Choung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287653/ https://www.ncbi.nlm.nih.gov/pubmed/32365474 http://dx.doi.org/10.3390/jcm9051281

Ejemplares similares

The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
por: Choi, Se Young, et al.
Publicado: (2021)

Hybrid ileal pouch with concomitant anti-refluxing and refluxing ureteroileal anastomosis
por: Choi, Se Young, et al.
Publicado: (2021)

Does intraoperative frozen section really predict significant positive surgical margins after robot-assisted laparoscopic prostatectomy? A retrospective study
por: Choi, Se Young, et al.
Publicado: (2020)

Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?
por: Yoo, Sagnjun, et al.
Publicado: (2021)

Impact of positive surgical margin on biochemical recurrence in localized prostate cancer
por: Lee, Wonchul, et al.
Publicado: (2021)

New drugs in prostate cancer
por: Yoo, Sangjun, et al.
Publicado: (2016)

A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways
por: Kim, Yunlim, et al.
Publicado: (2023)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
por: You, Dalsan, et al.
Publicado: (2015)

Prognosis of Prostate Cancer With Other Primary Malignancies
por: Lim, Ju Hyun, et al.
Publicado: (2014)

Clinical Experience with Limited Lymph Node Dissection for Prostate Cancer in Korea: Single Center Comparison of 247 Open and 354 Robot-Assisted Laparoscopic Radical Prostatectomy Series
por: Choi, Daeheon, et al.
Publicado: (2012)

Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?
por: Lee, Wonchul, et al.
Publicado: (2018)

Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015)

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
por: Song, Geehyun, et al.
Publicado: (2013)

Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia
por: Lee, Donghyun, et al.
Publicado: (2015)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka
por: Ogiwara, Katsueki, et al.
Publicado: (2013)

Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate
por: Kwon, Taekmin, et al.
Publicado: (2015)

Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea
por: Kim, Doejung, et al.
Publicado: (2012)

Novel roles of luteinizing hormone (LH) in tissue regeneration-associated functions in endometrial stem cells
por: Park, Se-Ra, et al.
Publicado: (2022)

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2014)

In vitro, in vivo, and clinical tests of a novel flexible ureteroscope for the diagnosis and treatment of kidney and ureteral diseases
por: Kim, Dai Hee, et al.
Publicado: (2018)

Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer
por: Nam, Wook, et al.
Publicado: (2018)

Retropubic Versus Robot-Assisted Laparoscopic Prostatectomy for Prostate Cancer: A Comparative Study of Postoperative Complications
por: Ryu, Jeman, et al.
Publicado: (2013)

Histologic Variability and Diverse Oncologic Outcomes of Prostate Sarcomas
por: Sohn, Mooyoung, et al.
Publicado: (2014)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy
por: Lee, Chunwoo, et al.
Publicado: (2015)

Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma
por: Kim, Aram, et al.
Publicado: (2015)

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
por: Koh, Yoko, et al.
Publicado: (2020)

The effect of overweight on the luteinizing hormone level after gonadorelin stimulation test in girls with idiopathic central precocious puberty
por: Lee, Hyun Young, et al.
Publicado: (2018)

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels
por: Okamoto, Kohei, et al.
Publicado: (2015)

Effect of follicle-stimulating hormone and luteinizing hormone levels on egg-laying frequency in hens
por: Prastiya, Ragil Angga, et al.
Publicado: (2022)

Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review
por: Zhang, Xianlu, et al.
Publicado: (2023)

Response of the corpus luteum to luteinizing hormone.
por: Niswender, G D
Publicado: (1981)

Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
por: Hong, Sungwoo, et al.
Publicado: (2013)

Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy
por: Jeong, In Gab, et al.
Publicado: (2013)

Adequacy of basal luteinizing hormone levels in the diagnosis of central precocious puberty
por: Vurallı, Doğuş, et al.
Publicado: (2020)

Expression of Luteinizing Hormone (LH) Subunit Genes in Mouse Testis
por: Kim, Hee Soo, et al.
Publicado: (2017)

Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients
por: Stroomberg, Hein Vincent, et al.
Publicado: (2020)

High Luteinizing Hormone and Lower Levels of Sex Hormones in Younger Men With Distal Radius Fracture
por: Egund, Lisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptorq61jti2vbv5q1cq3j3jmbq